로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Kits > Neuraminidase/NA (Influenza Virus) > RAS-A223

Influenza A (H1N1) Viruses Neuraminidase (NA) Specific ELISA Kit

For research use only.

Order Now

    Materials Provided
    IDComponentsSize
    RAS223-C01Pre-coated Anti-Influenza A (H1N1) Neuraminidase Antibody Microplate1 plate(8×12 strips)
    RAS223-C02Influenza A [A/Victoria/4897/2022(H1N1)] Neuraminidase Standard15 μg
    RAS223-C03HRP-Anti-Influenza A (H1N1) Neuraminidase Antibody20 μg
    RAS223-C0410×Washing Buffer 50 mL
    RAS223-C05Dilution Buffer50 mL
    RAS223-C06Substrate Solution12 mL
    RAS223-C07Stop Solution7 mL
  • Product Overview
    Influenza A (H1N1) Viruses Neuraminidase (NA) Specific ELISA Kit is based on the sandwich-ELISA method and is used to specifically detect and quantitatively determine the Influenza A (H1N1) viruses Neuraminidase (NA) in vaccine samples. The kit is designed to provide a reliable solution for the manufacturing and quality control of NA vaccine development.
  • Reconstitution
    Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.
  • Storage
    1. Unopened kit should be stored at 2℃-8℃ upon receiving.

    2. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

    3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

    Typical Data Please refer to DS document for the assay protocol.
     Neuraminidase/NA (Influenza Virus) TYPICAL DATA

    For each experiment, a standard curve needs to be set for each micro-plate, and the specific OD value may vary depending on different laboratories, testers, or equipments. The following example data is for reference only.

     Neuraminidase/NA (Influenza Virus) TYPICAL DATA

    The kit has been tested to specifically identify Influenza A [A/Victoria/4897/2022(H1N1)] NA and Influenza A [Wisconsin/67/2022(H1N1)] NA, and do not identify Influenza A (A/Croatia/10136RV/2023) & (A/District of Columbia/27/2023) NA(H3N2), Influenza A [A/Massachusetts/18/2022(H3N2)] NA, Influenza A [A/Thailand/8/2022(H3N2)] NA, Influenza A [Darwin/6/2021] NA, Influenza A [A/Darwin/9/2021 (H3N2)] NA, Influenza B [Austria/1359417/2021] NA and Influenza B [PHUKET/3073/2013] NA.

    • Clinical and Translational Updates

    Comments (0)

    Datasheet & Documentation

    Related Products

    New Product Launch

    Questions & Comments

    This web search service is supported by Google Inc.

    totop